BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 11723300)

  • 41. Case of primary diffuse leptomeningeal gliomatosis.
    Yamasaki K; Yokogami K; Ohta H; Yamashita S; Uehara H; Sato Y; Takeshima H
    Brain Tumor Pathol; 2014 Jul; 31(3):177-81. PubMed ID: 24473978
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Urticarial hypersensitivity reaction caused by temozolomide.
    Pothiawala S; Hsu MY; Yang C; Kesari S; Ibrahimi OA
    J Drugs Dermatol; 2010 Sep; 9(9):1142-4. PubMed ID: 20865848
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Concomitant viral and bacterial encephalitis after temozolomide for glioblastoma.
    Tsai JP; Petrescu N; Mason WP; Casaubon LK
    Can J Neurol Sci; 2014 Jan; 41(1):84-5. PubMed ID: 24384343
    [No Abstract]   [Full Text] [Related]  

  • 44. Prognostic factors for patients with gliomatosis cerebri: retrospective analysis of 17 consecutive cases.
    Inoue T; Kumabe T; Kanamori M; Sonoda Y; Watanabe M; Tominaga T
    Neurosurg Rev; 2010 Apr; 34(2):197-208. PubMed ID: 21301914
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Central diabetes insipidus: A rare unreported side effect of temozolomide in pediatrics.
    Kuo C; Foon D; Waters K; Cheung C; Margol AS
    Pediatr Blood Cancer; 2020 Dec; 67(12):e28516. PubMed ID: 32573959
    [No Abstract]   [Full Text] [Related]  

  • 46. Primary diffuse leptomeningeal gliomatosis in children: a clinical pathologic correlation.
    Bernardini FP; Croxatto JO; Nozza P; Rossi A; Capris P
    Ophthalmic Plast Reconstr Surg; 2013; 29(2):93-7. PubMed ID: 23247038
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Glioblastoma: If this is the "Temozolomide Era" Where is the Evidence?
    Perry JR
    Can J Neurol Sci; 2014 May; 41(3):301-2. PubMed ID: 24718814
    [No Abstract]   [Full Text] [Related]  

  • 48. Temozolomide chemotherapy of patients with recurrent anaplastic astrocytomas and glioblastomas.
    Sipos L; Vitanovics D; Afra D
    Ideggyogy Sz; 2004 Nov; 57(11-12):394-9. PubMed ID: 15662767
    [TBL] [Abstract][Full Text] [Related]  

  • 49. MSH6 inactivation and emergent temozolomide resistance in human glioblastomas.
    Cahill DP; Codd PJ; Batchelor TT; Curry WT; Louis DN
    Clin Neurosurg; 2008; 55():165-71. PubMed ID: 19248684
    [No Abstract]   [Full Text] [Related]  

  • 50. Radiochemotherapy in patients with primary glioblastoma comparing two temozolomide dose regimens: is the survival really so impressive?: in regard to Combs et al. (Int J Radiat Oncol Biol Phys 2008;71:999-1005).
    Jalali R
    Int J Radiat Oncol Biol Phys; 2008 Dec; 72(5):1622; author reply 1622-3. PubMed ID: 19028293
    [No Abstract]   [Full Text] [Related]  

  • 51. [Problems of chemotherapy for glioma].
    Hirose Y
    Gan To Kagaku Ryoho; 2011 Jun; 38(6):923-6. PubMed ID: 21751527
    [No Abstract]   [Full Text] [Related]  

  • 52. Case report: a patient with primary CNS lymphoma treated with temozolomide to complete response.
    Lerro KA; Lacy J
    J Neurooncol; 2002 Sep; 59(2):165-8. PubMed ID: 12241110
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A case of pediatric gliomatosis cerebri harboring H3F3A K27 mutation.
    Nakano Y; Yamasaki K; Satomi K; Fukushima H; Okuhiro Y; Okada K; Osugi Y; Sakamoto H; Inoue T; Yoshida A; Ichimura K; Hara J
    Pediatr Blood Cancer; 2020 Sep; 67(9):e28270. PubMed ID: 32965767
    [No Abstract]   [Full Text] [Related]  

  • 54. Temozolomide-related acute lymphoblastic leukemia with translocation (4;11)(q21;q23) in a glioblastoma patient.
    Chou KN; Lin YC; Liu MY; Chang PY
    J Clin Neurosci; 2014 Apr; 21(4):701-4. PubMed ID: 24291476
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Temozolomide treatment in glioma--experiences in two university hospitals in Finland.
    Mäenpää HO; Aaltonen K; Mäntylä R; Minn H
    Acta Oncol; 2004; 43(6):579-84. PubMed ID: 15370616
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Combined radiotherapy and temozolomide in patients with recurrent high grade glioma.
    Schönekaes K; Mücke R; Panke J; Rama B; Wagner W
    Tumori; 2002; 88(1):28-31. PubMed ID: 12004846
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Management and Survival Patterns of Patients with Gliomatosis Cerebri: A SEER-Based Analysis.
    Carroll KT; Hirshman B; Ali MA; Alattar AA; Brandel MG; Lochte B; Lanman T; Carter B; Chen CC
    World Neurosurg; 2017 Jul; 103():186-193. PubMed ID: 28366748
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Temozolomide chemotherapy in patients with recurrent malignant gliomas.
    Yang SH; Kim MK; Lee TK; Lee KS; Jeun SS; Park CK; Kang JK; Kim MC; Hong YK
    J Korean Med Sci; 2006 Aug; 21(4):739-44. PubMed ID: 16891823
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Intracranial metastatic esthesioneuroblastoma responsive to temozolomide.
    Wick W; Wick A; Küker W; Dichgans J; Weller M
    J Neurooncol; 2004 Oct; 70(1):73-5. PubMed ID: 15527110
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Temozolomide-associated myelodysplasia 6 years after treatment of a patient with pancreatic neuroendocrine tumor.
    Rashidi A; Sorscher SM
    Leuk Lymphoma; 2015; 56(8):2468-9. PubMed ID: 25530344
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.